Posted On: 10/02/2014 9:25:21 AM
Post# of 1145
TORONTO, ONTARIO and STORRS, CONNECTICUT--(Marketwired - Oct. 2, 2014) - POET Technologies Inc. (TSX VENTURE
TK)(OTCQXOETF) ("the Company"
- developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - announces that Dr. Geoff Taylor, Chief Scientist of the Company, has disposed of 300,000 common shares of the Company on October 1, 2014.
Dr. Taylor said "I want to stress that this sale was made for personal financial reasons, and in no way diminishes the belief I have in my life's work, that is POET. Furthermore, I do not plan on selling any additional shares until sometime in 2016."
This is the first disposition of shares by Dr. Taylor in over 3 years. Dr. Taylor still maintains a significant position in POET, currently 994,985 shares and 2,890,000 stock options.
TK)(OTCQXOETF) ("the Company" - developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - announces that Dr. Geoff Taylor, Chief Scientist of the Company, has disposed of 300,000 common shares of the Company on October 1, 2014. Dr. Taylor said "I want to stress that this sale was made for personal financial reasons, and in no way diminishes the belief I have in my life's work, that is POET. Furthermore, I do not plan on selling any additional shares until sometime in 2016."
This is the first disposition of shares by Dr. Taylor in over 3 years. Dr. Taylor still maintains a significant position in POET, currently 994,985 shares and 2,890,000 stock options.
(0)
(0)
